IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility
Chimeric antigen receptor (CAR) T cell therapies have made remarkable strides in treating high-risk B-cell malignancies since the first CAR-T,…
Analyst Comment
AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson’s
IO360 summit: CAR-T cell therapy applications beyond blood cancer
Weight loss implants to increase compliance and cut admin burden for patients
ACC 2025: GLP-1RAs may reduce incidence of AF/flutter and stroke in diabetic patients
ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
CNS market resurgence: a decade-long slump ends with $80bn milestone
Reshoring efforts in US FMCG business begins, but cost increases are likely
